All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies.
Thomas P LodiseMatteo BassettiRicard FerrerThierry NaasYoshihito NikiDavid L PatersonMarkus ZeitlingerRoger EcholsPublished in: Expert review of anti-infective therapy (2022)
. More pathogen-focused, randomized, controlled clinical trials with more feasible design and higher patient numbers are needed to demonstrate clinical benefit in drug-resistant infections.